VOINOSIS
VOINOSIS is a Seoul-based AI healthcare company founded in 2019 by otolaryngologist Shin Jung-eun.
About
VOINOSIS is a Seoul-based AI healthcare company founded in 2019 by otolaryngologist Shin Jung-eun. It analyzes voice and hearing data to screen early for cognitive decline and dementia (including MCI and early Alzheimer's) and to manage age-related hearing loss, with products such as BrainGuard Doctor, VoiceCheck/Voice Wellness, HaHa Care and BrainGuard Therapy.
Founders / core team
Similar companies· Same sector “Life Sciences”
Cent
Life SciencesCent is a Bengaluru-based direct-to-consumer preventive healthcare company founded in 2025 by Practo co-founder Shashank ND, running clinical prevention centres that combine whole-body MRI, CT, DEXA and 100+ biomarkers with an in-house AI system that synthesises multimodal data into risk scores.
Tiny Health
Life SciencesTiny Health, founded in 2020 in Austin, Texas, started with infant gut health in the first 1,000 days and offers at-home gut and vaginal microbiome testing across the lifespan. Its TinyAI, trained on nearly 200,000 proprietary microbiome profiles, delivers personalized guidance tied to results; it serves nearly 200,000 customers and more than 6,000 healthcare practitioners.
Network Bio
Life SciencesNetwork Bio is a Palo Alto, California biotechnology company founded in 2022 that builds disease-specific AI models from human biological data. Its vertically integrated platform combines a biological research network that sources, links and structures tissue, blood and longitudinal clinical outcomes from leading U.S. academic medical centers (Mass General Brigham, University of Pennsylvania, Duke University, University of Colorado Anschutz and UCSF, spanning 500,000+ patients across oncology, immunology, metabolic and cardiovascular disease) into AI-ready datasets, with a bio-native AI architecture purpose-built to learn from multimodal biological data, overcome technical confounders and batch effects, and generate interpretable representations of disease biology that generalize across diseases, tissues and modalities.
Lucis
Life SciencesLucis, founded in 2024 in Paris, France, helps consumers monitor metabolic health, hormone levels, cardiovascular risk, inflammation, and nutritional status based on blood biomarker analysis and AI-driven recommendations.
SuperDial
Life SciencesSuperDial, founded in 2021 in San Francisco, USA, builds AI voice agents that handle insurance verification and billing follow-up calls for healthcare providers. The startup envisions a future where healthcare coordination is agent-powered—where payers, providers, pharmacies, labs, and other healthcare organizations can communicate with each other AI-to-AI.
Kraionyx AI
Life SciencesFounded in 2025 in Hyderabad, India, Kraionyx AI builds high-assurance agentic AI systems for healthcare as "the intelligence layer" for clinicians: KareOS (clinical decision-support workspace with specialist medical agents), Svaani (ambient voice intelligence turning doctor-patient conversations into clinical documentation) and Doclave (a professional network for doctors to discuss cases).
Investors that may fit
Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.